Cutaneous amebiasis: diagnostic challenges in a rare genital presentation

Authors

  • Shilpa D. Hirani Department of Pharmacology, Gujarat Adani Institute of Medical Science, Bhuj, Gujarat, India
  • Aakash N. Shah Department of Pharmacology, Gujarat Adani Institute of Medical Science, Bhuj, Gujarat, India
  • Arti N. Shah Department of Pharmacology, Gujarat Adani Institute of Medical Science, Bhuj, Gujarat, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20253400

Keywords:

Cutaneous amoebiasis, Entamoeba histolytica, Genital ulcer, Metronidazole, Diagnostic biopsy, Tissue biopsy

Abstract

Cutaneous amebiasis (CA) is a rare, often misdiagnosed manifestation of Entamoeba histolytica infection, typically associated with gastrointestinal disease. Its non-specific presentation mimics malignancies or ulcerative conditions, posing diagnostic challenges, particularly in endemic areas with poor sanitation. A 35-year-old immunocompetent female presented with a two-month history of a non-healing ulcer (4×3 cm) on the labia majora and minora, initially misdiagnosed as genital herpes. Despite treatment with valacyclovir, corticosteroids, and empirical antibiotics (doxycycline, nadifloxacin, and azithromycin), the ulcer persisted. Examination revealed a painful ulcer with undermined margins, necrotic slough, and erythema, without systemic symptoms. Laboratory tests (negative ANA, HIV, and Tzanck smear) ruled out autoimmune and viral causes. Histopathological biopsy confirmed CA, showing E. histolytica trophozoites, hyperplastic squamous epithelium, and chronic inflammation. Oral metronidazole (400 mg thrice daily) and topical metronidazole achieved significant healing within two weeks and complete resolution by one month. The case highlights the diagnostic complexity of cutaneous amoebiasis, as its genital presentation resembles herpes or malignancy. Histopathology was critical for diagnosis, especially without intestinal involvement, suggesting possible nosocomial or hygiene-related transmission. Metronidazole’s efficacy aligns with standard protocols, but CA’s rarity delays recognition. Cutaneous amoebiasis requires heightened clinician awareness to avoid misdiagnosis. Histopathological confirmation and prompt metronidazole therapy ensure excellent outcomes. Enhanced vigilance and public health measures are essential in endemic regions to manage this rare, treatable condition effectively.

Metrics

Metrics Loading ...

References

Eichelmann K, Tomecki KJ, Martínez JD. Tropical dermatology: cutaneous larva migrans, gnathostomiasis, cutaneous amebiasis and trombiculiasis. Semin Cutan Med Surg. 2014;33:133-5. DOI: https://doi.org/10.12788/j.sder.0109

Parshad S, Grover PS, Sharma A, Verma DK, Sharma A. Primary cutaneous amoebiasis: case report with review of the literature. Int J Dermatol. 2020;41(10):676-80. DOI: https://doi.org/10.1046/j.1365-4362.2002.01569.x

Fernández-Díez J, Magaña M, Magaña ML. Cutaneous amebiasis: 50 years of experience. Cutis. 2012;90:310-4.

Veasey JV, Moreira HP, Hafner MFS, Lellis RF. Cutaneous amoebiasis: a dermatological rarity. An Bras Dermatol. 2025;100(1):200-3. DOI: https://doi.org/10.1016/j.abd.2024.04.008

Nasse D. Coincidental amoebic liver abscess; dysentery and nosocomial gangrene. Arch F Klin Chir. 1892;43:40-53.

En WL, Ding CSL, Suresh KN, Lim PL. A bedbound 71-year-old Singaporean male nursing home resident with an ulcerating perianal mass. Clin Infect Dis. 2020;72(4):718-9. DOI: https://doi.org/10.1093/cid/ciaa916

Morán P, Serrano-Vázquez A, Rojas-Velázquez L, González E, Pérez-Juárez H, Hernández EG, et al. Amoebiasis: advances in diagnosis, treatment, immunology features and the interaction with the intestinal ecosystem. Int J Mol Sci. 2023;24(14):11755. DOI: https://doi.org/10.3390/ijms241411755

Ximénez C, Morán P, Rojas L, Valadez A, Gómez A, Ramiro M, et al. Novelties on amoebiasis: a neglected tropical disease. J Glob Infect Dis. 2011;3(2):166-74. DOI: https://doi.org/10.4103/0974-777X.81695

Kantor M, Abrantes A, Estevez A, Schiller A, Torrent J, Gascon J, et al. Entamoeba histolytica: updates in clinical manifestation, pathogenesis, and vaccine development. Can J Gastroenterol Hepatol. 2018;2018:1-6. DOI: https://doi.org/10.1155/2018/4601420

Shirley DT, Farr L, Watanabe K, Moonah S. A review of the global burden, new diagnostics, and current therapeutics for amebiasis. Open Forum Infect Dis. 2018;5(7). DOI: https://doi.org/10.1093/ofid/ofy161

Marie C, Petri WA Jr. Regulation of virulence of Entamoeba histolytica. Annu Rev Microbiol. 2015;69:349-67.

Hung CC, Chang SC, Chen PJ. Sexual transmission of Entamoeba histolytica infection: a systematic review. J Travel Med. 2020;27(5):taaa050.

Saidin S, Othman N, Noordin R. Update on laboratory diagnosis of amoebiasis. Eur J Clin Microbiol Infect Dis. 2019;38(1):15-38. DOI: https://doi.org/10.1007/s10096-018-3379-3

Downloads

Published

2025-10-25

How to Cite

Hirani, S. D., Shah, A. N., & Shah, A. N. (2025). Cutaneous amebiasis: diagnostic challenges in a rare genital presentation. International Journal of Research in Dermatology, 11(6), 537–540. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20253400